Department of Veterans Affairs awards $6.2 million to VA Providence for Neurological Research to advance Veterans Health

 

PROVIDENCE, R.I. – The Department of Veterans Affairs has approved a research award of $6.2 million, effective June 1, 2023, for the VA Providence Healthcare System to support a full range of translational research, from understanding basic mechanisms of nervous system function to developing and implementing novel treatments for complex neurological and mental health disorders.

The funding supports the VA Rehabilitation Research and Development Service (RR&D) Center for Neurorestoration and Neurotechnology (CfNN) located at VA Providence Healthcare System. The funding represents the 2nd renewal for CfNN, which was first funded in 2012.

“We are extremely fortunate to have world class research conducted by extremely talented researchers and scientists here at the VA Providence Healthcare System,” says Lawrence Connell, VA Providence Healthcare System Director, “our research will ultimately improve the lives of our Veterans and the general public at large,” he said.

CfNN is one of 12 centers funded by VA RR&D dedicated to advancing Veterans Health through neuroengineering and clinical neurorehabilitation research.  CfNN’s vision is to improve the physical function, mental health and functioning, and quality of life of Veterans. Since 2012, CfNN has facilitated deeply collaborative research between its scientists, VA Providence and other RR&D Center researchers, and CfNN’s university and hospital affiliates.

“The multidisciplinary cutting-edge research done by investigators at CfNN has the potential to dramatically improve the lives of our Veterans suffering from neurological and mental health disorders and disabilities. With this renewal, our research team at VA Providence will continue in their endeavor to bring novel device-based therapies from research labs to the clinic,” said Gaurav Choudhary MD, Associate Chief of Staff (Research) at VA Providence. 

CfNN is led by Leigh R. Hochberg, MD, PhD who is a neurologist at the VA, the L. Herbert Ballou University Professor of Engineering and Professor of Brain Science at Brown University, and director of the Center for Neurotechnology and Neurorecovery at Massachusetts General Hospital. He was the recipient of the 2022 VA Paul B. Magnuson Award, the highest research award in VA RR&D.  “Restoring communication, mobility, mental health, and limb and sensory function are key priorities for Veterans Health. We are thrilled to have the opportunity to continue our research to develop new neurotechnology-based therapies to improve the health and function of Veterans with neurologic or mental health disorders, and to help recruit and advance the next generation of neurorestoration researchers,” said Dr. Hochberg. Benjamin Greenberg, MD, PhD, CfNN’s Associate Director and Professor of Psychiatry and Human Behavior at Brown, said, “This is an incredibly exciting time for making real differences in brain and behavioral disorders for Veterans. We are getting better at understanding how functioning in circuits in the brain give rise to mental health or neurologic disorders. And advances in technology promise to allow us to engage those brain pathways to relieve suffering and improve the lives of Veterans with these illnesses. We’re honored to be able to continue CfNN’s work to support our nation’s Veterans and others with neurologic disease or injury.”

Patricia A. Dorn, PhD, VA’s Director of RR&D, said, “It is vital to continue to support the research and mentoring conducted by the outstanding CfNN team of investigators as they make groundbreaking discoveries to improve the lives of Veterans with neurological and mental health conditions. Through the Leadership of Drs. Hochberg and Greenberg, CfNN successfully carries out its mission for Veterans to develop, test, and implement new therapies and technologies to restore function in disorders of the nervous system that impair movement, emotion, or cognition.”

For more information about the center, please see centerforneuro.org.

 

 

 

 

Former President Trump is complaining that he can't be on the campaign trail because of what he calls a ridiculous trial in New York City. Speaking right after the 12 jurors were selected on Thursday, Trump said the "whole world is watching this scam" and went on to read news articles criticizing the case. The judge hopes to have the six alternates selected by Friday.        House Speaker Mike Johnson needs the help of Democrats to get his foreign aid package across the finish line. Johnson is moving forward with a plan to vote on separate bills to send military assistance to Ukraine, Israel, and U.S. allies in the Indo-Pacific, as well as a bill that includes border security measures. However, several conservatives quickly came out against the plan, arguing border policy changes should be directly tied to any additional funding for Ukraine.        The United States plans to veto a Palestinian bid to be recognized as a full member of the United Nations. The State Department calls the Palestinian Authority's effort to gain member status premature. The department said the Security Council's 15 members do not fully agree that the Palestinian Authority met the membership criteria, including standing questions about who governs the Gaza Strip.       The FBI is concerned about threats to Jewish communities in the U.S. as Passover approaches. FBI Director Christopher Wray spoke during an event on Wednesday hosted by a Jewish community nonprofit safety and training organization called Secure Community Network. Wray told the group of security officials the FBI looks for "lone actors" who might target high profile events or religious locations for violence.        Attorneys for Idaho murder suspect Bryan Kohberger filed their client's alibi defense just ahead of the deadline. The 29-year-old Kohberger is accused of fatally stabbing four University of Idaho students in November of 2022, and has pleaded not guilty. Late Wednesday, Kohberger's lawyers submitted a ten-page filing that claimed he was out driving in the early morning hours of November 13th, "as he often did to hike and run and/or see the moon and stars."        Allman Brothers Band singer-guitarist Dickey Betts has died at the age of 80. They said Betts passed away peacefully Thursday at his home in Osprey, Florida surrounded by his family. Betts wrote and sung on the Allman Brothers Band hit "Ramblin' Man" which peaked at number two on the Billboard Hot 100 chart.